• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 07 Dec 2023

DRX: Q3 Financials Smash Expectations; Increasing Target Price


ADF Group Inc. (DRX:TSE) | 0 0 -1.9% | Mkt Cap: 38.0m


  • Atrium Research
    • Nicholas Cortellucci, CFA

    • 5 pages


 

What you need to know: • ADF reported stellar Q3 financials that largely beat our estimates. Once again, the robotic fabrication line led the major improvements. • Revenue came in at $82.1M (+26% YoY) vs. our estimate of $73.0M and EBITDA came in at $17.8M (+146% YoY) vs. our estimate of $7.7M. • ADF continues to only trade at 3.6x FY24E EBITDA and 1.1x BV. This morning, ADF Group (DRX:TSX, ADFJF:OTC) reported Q3/24 financial results that largely beat our estimates across the board. The beat was driven by further margin improvements from its robotic fabrication line. We remain highly convicted in the investment thesis laid out in our initiation report from October (read here) as ADF progresses through this infrastructure spending cycle and takes advantage of its new automated fabrication line. We are maintaining our BUY rating and increasing our target to $9.00/share (previously $8.00/share) on ADF. Key Highlights • Revenue for Q3 came in at $82.1M compared to our estimate of $73.0M and $65.0M last year. This represents 26% YoY growth and 2% QoQ growth. The significant growth was driven by the execution of projects in the backlog. Fabrication hours represented 42% of revenue and 42% of the backlog, up from 21% of the backlog last year. • The order backlog came in at $339.3M (vs. $373.7M last quarter), extending until January 2025. • Gross margin for the quarter came in at 24% vs. our estimate of 19% and 15% in Q3 last year. Management attributed the improvement to its robotic production line as well as higher margins on new projects. • Adj. EBITDA came in at $17.8M (22% EBITDA margin, +146% YoY, +41% QoQ) compared to our estimate of $7.7M (11% margin). This compares to the low/mid-single-digit margins posted over the last few years. • EPS came in at $0.34 ($11.2M net income, +285% YoY) compared to our estimate of $0.13/share ($4.3M). This brought annualized ROE to 29% and annualized ROIC to 31%. • ADF posted $3.2M in capex, translating to ($7.4M) in FCF in Q3, which was negative largely due to an increase in A/R and contract assets. • The Company ended the quarter with $44.0M in cash and $49.6M in debt.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

DRX: Q3 Financials Smash Expectations; Increasing Target Price


ADF Group Inc. (DRX:TSE) | 0 0 -1.9% | Mkt Cap: 38.0m


  • Published: 07 Dec 2023
  • Author: Nicholas Cortellucci, CFA
  • Pages: 5
  • Atrium Research


What you need to know: • ADF reported stellar Q3 financials that largely beat our estimates. Once again, the robotic fabrication line led the major improvements. • Revenue came in at $82.1M (+26% YoY) vs. our estimate of $73.0M and EBITDA came in at $17.8M (+146% YoY) vs. our estimate of $7.7M. • ADF continues to only trade at 3.6x FY24E EBITDA and 1.1x BV. This morning, ADF Group (DRX:TSX, ADFJF:OTC) reported Q3/24 financial results that largely beat our estimates across the board. The beat was driven by further margin improvements from its robotic fabrication line. We remain highly convicted in the investment thesis laid out in our initiation report from October (read here) as ADF progresses through this infrastructure spending cycle and takes advantage of its new automated fabrication line. We are maintaining our BUY rating and increasing our target to $9.00/share (previously $8.00/share) on ADF. Key Highlights • Revenue for Q3 came in at $82.1M compared to our estimate of $73.0M and $65.0M last year. This represents 26% YoY growth and 2% QoQ growth. The significant growth was driven by the execution of projects in the backlog. Fabrication hours represented 42% of revenue and 42% of the backlog, up from 21% of the backlog last year. • The order backlog came in at $339.3M (vs. $373.7M last quarter), extending until January 2025. • Gross margin for the quarter came in at 24% vs. our estimate of 19% and 15% in Q3 last year. Management attributed the improvement to its robotic production line as well as higher margins on new projects. • Adj. EBITDA came in at $17.8M (22% EBITDA margin, +146% YoY, +41% QoQ) compared to our estimate of $7.7M (11% margin). This compares to the low/mid-single-digit margins posted over the last few years. • EPS came in at $0.34 ($11.2M net income, +285% YoY) compared to our estimate of $0.13/share ($4.3M). This brought annualized ROE to 29% and annualized ROIC to 31%. • ADF posted $3.2M in capex, translating to ($7.4M) in FCF in Q3, which was negative largely due to an increase in A/R and contract assets. • The Company ended the quarter with $44.0M in cash and $49.6M in debt.

More Content

More Content

DRX: Record FY Financials; Lowering Estimates on Tariff Impacts

Companies: ADF Group Inc.

Atrium Research

Small-Caps with Torque to Infrastructure Spending

Companies: DRX CEMX QTRH GRID

Atrium Research

Q1/25 Recap: All Our Research in One Place!

Companies: NIM SCZ DRX AUAU ARG OMG BQE DNG EDG KNR MOO NIM RIO SBIO LVG TOC TM SCZ CAPT GIGA APM FISH

Atrium Research

DRX: Value Stock Entering Multi-Year Growth Cycle

Companies: ADF Group Inc.

Atrium Research

DRX: Back at It Again; $120M in New Contracts Signed

Companies: ADF Group Inc.

Atrium Research
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Acquisdata
      • Actinver
      • Actio Advisors
      • Asset TV
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Brand Communications
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD (hosted by Progressive)
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In